JP2012530509A5 - - Google Patents

Download PDF

Info

Publication number
JP2012530509A5
JP2012530509A5 JP2012516776A JP2012516776A JP2012530509A5 JP 2012530509 A5 JP2012530509 A5 JP 2012530509A5 JP 2012516776 A JP2012516776 A JP 2012516776A JP 2012516776 A JP2012516776 A JP 2012516776A JP 2012530509 A5 JP2012530509 A5 JP 2012530509A5
Authority
JP
Japan
Prior art keywords
fusion protein
amino acid
endolysin
acid residues
protein according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012516776A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012530509A (ja
JP6034187B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/059146 external-priority patent/WO2010149792A2/en
Publication of JP2012530509A publication Critical patent/JP2012530509A/ja
Publication of JP2012530509A5 publication Critical patent/JP2012530509A5/ja
Application granted granted Critical
Publication of JP6034187B2 publication Critical patent/JP6034187B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012516776A 2009-06-26 2010-06-28 抗微生物剤 Active JP6034187B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09163953 2009-06-26
EP09163953.4 2009-06-26
PCT/EP2010/059146 WO2010149792A2 (en) 2009-06-26 2010-06-28 Antimicrobial agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016113291A Division JP2017008033A (ja) 2009-06-26 2016-06-07 抗微生物剤

Publications (3)

Publication Number Publication Date
JP2012530509A JP2012530509A (ja) 2012-12-06
JP2012530509A5 true JP2012530509A5 (https=) 2013-08-15
JP6034187B2 JP6034187B2 (ja) 2016-11-30

Family

ID=42799668

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012516776A Active JP6034187B2 (ja) 2009-06-26 2010-06-28 抗微生物剤
JP2016113291A Pending JP2017008033A (ja) 2009-06-26 2016-06-07 抗微生物剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016113291A Pending JP2017008033A (ja) 2009-06-26 2016-06-07 抗微生物剤

Country Status (17)

Country Link
US (3) US8906365B2 (https=)
EP (3) EP2445515B1 (https=)
JP (2) JP6034187B2 (https=)
KR (2) KR20170024129A (https=)
CN (2) CN102458452B (https=)
AU (3) AU2010264656B2 (https=)
BR (1) BRPI1015192A2 (https=)
CA (1) CA2764131C (https=)
DK (1) DK2445515T3 (https=)
EA (1) EA037202B1 (https=)
ES (1) ES2579806T3 (https=)
IL (2) IL217124A (https=)
MX (2) MX360300B (https=)
PL (1) PL2445515T3 (https=)
SG (1) SG177370A1 (https=)
SI (1) SI2445515T1 (https=)
WO (1) WO2010149792A2 (https=)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
KR101701890B1 (ko) 2009-06-26 2017-02-02 뤼산도 아게 항균제
DK2445515T3 (en) 2009-06-26 2016-07-04 Univ Leuven Kath antimicrobial agents
SG178440A1 (en) 2009-08-24 2012-04-27 Univ Leuven Kath New endolysin obpgplys
EA037276B1 (ru) * 2010-04-27 2021-03-03 Лисандо Аг Способы устранения или уменьшения бактериальной биопленки
EP2468856A1 (en) * 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents
CN103635584B (zh) 2011-04-12 2017-10-27 冈戈根股份有限公司 嵌合抗菌多肽
US9068204B2 (en) 2013-03-15 2015-06-30 The United States Of America, As Represented By The Secretary Of Agriculture Peptidoglycan hydrolase antimicrobials for eradicating lactobacilli that contaminate and reduce ethanol yields in biofuel fermentation
WO2015070912A1 (en) * 2013-11-14 2015-05-21 Lysando Ag Modified el188 endolysin sequence
WO2015070911A1 (en) * 2013-11-14 2015-05-21 Lysando Ag Modified kz144 endolysin sequence
WO2015121443A1 (en) 2014-02-14 2015-08-20 Lysando Ag Antimicrobial agents
CA2941426C (en) * 2014-04-08 2022-09-27 Lysando Ag Pharmaceutical composition against chronic bacterial infections
AU2015279705B2 (en) * 2014-06-26 2021-04-01 The Rockefeller University Acinetobacter lysins
CN105734029B (zh) * 2014-12-12 2020-09-25 丰益(上海)生物技术研发中心有限公司 磷脂酶抗菌肽
AU2016324307B2 (en) 2015-09-17 2021-10-21 Contrafect Corporation Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
CN105175509A (zh) * 2015-10-19 2015-12-23 河南科技学院 一种抗菌肽xyz-1及其应用
CA3014442A1 (en) * 2016-02-29 2017-09-08 Dana-Farber Cancer Institute, Inc. Stapled intracellular-targeting antimicrobial peptides to treat infection
AU2017255962B2 (en) * 2016-04-28 2023-02-23 Lysando Ag Antimicrobial agents against Salmonella bacteria
WO2018100408A1 (en) 2016-11-30 2018-06-07 Sasinapas Co.,Ltd. Modified peptides
AU2017375050B2 (en) * 2016-12-16 2021-07-22 Universidade Do Minho Novel endolysin
US20180208938A1 (en) * 2017-01-23 2018-07-26 Innate Immunity LLC Compositions and Methods for Protecting Plants Against Bacterial Infections
AU2018248060B2 (en) * 2017-04-03 2024-05-23 Sasinapas Co., Ltd. Engineered Gram-negative endolysins
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
WO2019155002A1 (en) * 2018-02-08 2019-08-15 Institut Pasteur Anti-prevotella bacteriocin methods and compositions
CN112368376A (zh) * 2018-03-29 2021-02-12 康特拉费克特公司 溶素-抗微生物肽(amp)多肽构建体、溶素、其分离的编码多核苷酸及其用途
WO2020046747A1 (en) * 2018-08-23 2020-03-05 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
CN108410840A (zh) * 2018-04-03 2018-08-17 大连理工大学 一种铜绿假单胞菌噬菌体内溶素及其编码基因与应用
JP6979210B2 (ja) * 2018-04-26 2021-12-08 株式会社ニューギン 遊技機
EP3802620A1 (en) * 2018-05-30 2021-04-14 Lysando AG Novel antimicrobial fusion proteins
US11958890B2 (en) 2018-05-30 2024-04-16 Lysando Ag Antimicrobial proteins
WO2021007107A1 (en) * 2019-07-05 2021-01-14 Contrafect Corporation Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative and acid-fast bacteria
MX2022011291A (es) 2020-03-11 2022-12-08 Telum Therapeutics S L Nueva lisina recombinante y su uso en el tratamiento de infecciones por bacterias gramnegativas.
CA3171721A1 (en) 2020-03-19 2021-09-23 Fritz Eichenseher A stabilized protein of interest
WO2021235876A1 (ko) * 2020-05-22 2021-11-25 주식회사 라이센텍 신규한 폴리펩타이드, 융합 폴리펩타이드, 및 이를 포함하는 그람음성균에 대한 항생제
KR102286544B1 (ko) * 2021-02-10 2021-08-05 주식회사 라이센텍 융합 폴리펩타이드 및 이를 포함하는 그람음성균에 대한 항생제
EP4182334A4 (en) * 2020-07-17 2024-10-16 The University Of Western Australia COMPOSITIONS AND METHODS OF TREATMENT OF CANCER
CN111876400B (zh) * 2020-08-06 2022-05-24 昆明理工大学 一种常温裂解酶Sly和编码此酶的多核苷酸
SK289101B6 (sk) * 2020-12-17 2023-08-09 Ústav molekulárnej biológie Slovenskej akadémie vied, verejná výskumná inštitúcia Antimikrobiálny proteín, antimikrobiálny rekombinantný proteín s lytickými vlastnosťami, expresný vektor, spôsob ich prípravy a použitie
US11548917B1 (en) * 2021-11-24 2023-01-10 Intron Biotechnology, Inc. Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
WO2024241070A1 (en) 2023-05-22 2024-11-28 L'oreal Cosmetic composition comprising an endolysin and a polyvinyl alcohol
FR3149202B1 (fr) 2023-06-02 2026-04-10 Oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et une huile.
FR3152395A1 (fr) 2023-08-28 2025-03-07 L'oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et la 4-hydroxyacetophenone
FR3149205B1 (fr) 2023-06-02 2026-04-24 Oreal Composition cosmétique comprenant une endolysine et un agent de charge organique
FR3149204B1 (fr) 2023-06-02 2026-02-13 Oreal Composition cosmétique comprenant une endolysine et un tensioactif non ionique comprenant un résidu carbohydrate
FR3149209B1 (fr) 2023-06-02 2026-04-03 Oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique
FR3149208B1 (fr) 2023-06-02 2026-03-20 Oreal Composition cosmétique, notamment aqueuse, comprenant une endolysine et un pullulane
FR3149203B1 (fr) 2023-06-02 2026-03-13 Oreal Composition anhydre comprenant une endolysine et de l’hydroxypropylmethylcellulose et/ou du pullulane
EP4719330A1 (en) 2023-06-02 2026-04-08 L'oreal Cosmetic composition comprising an endolysin derived from a staphylococcus aureus phage and an aromatic alcohol
FR3149206B1 (fr) 2023-06-02 2026-03-13 Oreal Composition cosmétique aqueuse comprenant une endolysine et du tréhalose
FR3149207B1 (fr) 2023-06-02 2026-03-13 Oreal Composition cosmétique comprenant une endolysine et un composé de formule (I)
FR3152394B1 (fr) 2023-08-28 2026-04-24 Oreal Composition cosmétique comprenant une endolysine et des particules d’aérogel de silice hydrophobe
FR3152396A1 (fr) 2023-08-28 2025-03-07 L'oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un polyhydroxyalcane
FR3152393B1 (fr) 2023-08-28 2026-04-24 Oreal Composition cosmétique comprenant une endolysine dérivée d’un phage de Staphylococcus aureus et une charge minérale
WO2025093666A1 (en) 2023-11-01 2025-05-08 University Of Copenhagen Treatment of lymphoma
CN117534733B (zh) * 2024-01-10 2024-03-29 黑龙江八一农垦大学 抗菌肽cm24、重组基因、乳酸工程菌及其应用
CN118895244B (zh) * 2024-07-23 2025-06-20 浙江自贸区中航生物科技有限责任公司 一种提高nk细胞杀伤活性的多肽及其应用
WO2026052743A1 (en) 2024-09-04 2026-03-12 Micreos Human Health B.V. Reduction of trans-epidermal water loss by a polypeptide with antibacterial properties

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000194A1 (en) * 1987-07-06 1989-01-12 Louisiana State University Agricultural And Mechan Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides
GB8816693D0 (en) 1988-07-13 1988-08-17 Agricultural & Food Res Viral enzyme & gene
GB2255561B (en) 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
ATE233817T1 (de) 1992-08-21 2003-03-15 Univ British Columbia Kationische peptide und verfahren zu deren herstellung
ATE198119T1 (de) 1994-09-01 2001-01-15 Novo Nordisk As Eine grundlegende proteinzusammensetzung zur abtötung oder inhibierung mikrobieller zellen
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US5997862A (en) 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections
US20030113298A1 (en) * 1997-10-31 2003-06-19 Vincent Fischetti Use of bacterial phage associated lysing proteins for the prophylactic and therapeutic treatment of various illnesses
US6428784B1 (en) 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6288212B1 (en) * 1998-08-28 2001-09-11 The University Of British Columbia Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
US5993809A (en) 1998-11-18 1999-11-30 Children's Hospital Medical Center Lysozyme fusion proteins in infections
EP1194570A1 (en) * 1999-06-23 2002-04-10 PPL Therapeutics (Scotland) Limited Fusion proteins incorporating lysozyme
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
CA2482995C (en) 2002-04-22 2013-01-29 Dow Global Technologies Inc. Low-cost production of peptides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
JP2007504810A (ja) * 2003-09-11 2007-03-08 ノボザイムス アクティーゼルスカブ 抗微生物剤の組換え製造
WO2005108563A2 (en) 2004-04-19 2005-11-17 University Of Chicago Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
US7572602B1 (en) 2004-12-03 2009-08-11 The United States Of America As Represented By The Secretary Of Agriculture Nucleic acid encoding endolysin fusion protein
DE102005040347A1 (de) 2005-08-25 2007-03-01 Profos Ag Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von Listerien
US7943128B2 (en) 2006-03-31 2011-05-17 The University Court Of The University Of St Andrews Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase
DE102006061002A1 (de) 2006-12-22 2008-06-26 Profos Ag Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien
US8586709B2 (en) * 2007-09-25 2013-11-19 Pastoral Greenhouse Research Limited Cell-permeabilising peptides and polypeptides for microbial cells
AU2008328584A1 (en) 2007-11-26 2009-06-04 Plant Bioscience Limited Novel polypeptides having endolysin activity and uses thereof
CA2736062A1 (en) 2008-07-24 2010-01-28 The United State Of America, As Represented By The Secretary Of Agricuure Triple acting antimicrobials that are refractory to resistance development
EP2157100A1 (en) 2008-08-19 2010-02-24 Profos AG Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
JP5654493B2 (ja) * 2009-02-03 2015-01-14 アプライド・バイオミメティック・エイ/エス 重合プロテオリポソームを用いたナノ加工膜
WO2010091294A2 (en) 2009-02-05 2010-08-12 The Regents Of The University Of California New targeted antimicrobial moieties
US8383102B2 (en) 2009-05-21 2013-02-26 The United States Of America As Represented By The Secretary Of Agriculture Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens
DK2445515T3 (en) 2009-06-26 2016-07-04 Univ Leuven Kath antimicrobial agents
KR101701890B1 (ko) 2009-06-26 2017-02-02 뤼산도 아게 항균제
SG178440A1 (en) 2009-08-24 2012-04-27 Univ Leuven Kath New endolysin obpgplys
EA037276B1 (ru) 2010-04-27 2021-03-03 Лисандо Аг Способы устранения или уменьшения бактериальной биопленки
WO2014001571A1 (en) 2012-06-29 2014-01-03 Lysando Ag Composition for use in mycobacteria diagnosis

Similar Documents

Publication Publication Date Title
JP2012530509A5 (https=)
JP2014500714A5 (https=)
JP2012530510A5 (https=)
JP2012500642A5 (https=)
JP6034187B2 (ja) 抗微生物剤
JP5847081B2 (ja) エンドリシンOBPgpLYS
TWI527521B (zh) 減少生物膜的方法
JP5571757B2 (ja) 抗微生物剤
Yount et al. Emerging themes and therapeutic prospects for anti-infective peptides
JP2021519083A5 (https=)
MX2011013453A (es) Agentes antimicrobianos.
EA201370145A1 (ru) Антимикробные средства
Sivieri et al. Gut microbiota and antimicrobial peptides
JP2014500714A (ja) 新規エンドリシン
BR112019007979A2 (pt) novos agentes antimicrobianos contra bactérias enterococcus
Nagarajan et al. Peptide therapeutics versus superbugs: highlight on current research and advancements
WO2016209173A1 (en) Broad-spectrum anti-infective peptides
EA201991233A1 (ru) Новый эндолизин
CN112368010A (zh) 抗微生物的、细菌噬菌体来源的多肽及其针对革兰氏阴性细菌的用途
Weeks et al. Antimicrobial peptides and peptidomimetics for the control of antimicrobial resistance
JP2016521685A5 (https=)
Oliveira et al. The Challenging of Antibiotic Resistance in the Development of New Therapeutics
Wang Characterized analysis of peptide QUB-1433 from the skin secretion of the dark-spotted frog (Pelophylax nigromaculatus)
TH120358A (th) สารต้านจุลินทรีย์ (antimicrobial aggents)
Sahin et al. Structure and function of antimicrobial peptides as alternatives to traditional antibiotics